Phospholipase A2 of Peroxiredoxin 6 Has a Critical Role in Tumor Necrosis Factor-Induced Apoptosis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Formaldehyde Induces Bone Marrow Toxicity in Mice by Inhibiting Peroxiredoxin 2 Expression
MOLECULAR MEDICINE REPORTS 10: 1915-1920, 2014 Formaldehyde induces bone marrow toxicity in mice by inhibiting peroxiredoxin 2 expression GUANGYAN YU1, QIANG CHEN1, XIAOMEI LIU1, CAIXIA GUO2, HAIYING DU1 and ZHIWEI SUN1,2 1Department of Preventative Medicine, School of Public Health, Jilin University, Changchun, Jilin 130021; 2 Department of Hygenic Toxicology, School of Public Health, Capital Medical University, Beijing 100069, P.R. China Received November 4, 2013; Accepted June 5, 2014 DOI: 10.3892/mmr.2014.2473 Abstract. Peroxiredoxin 2 (Prx2), a member of the perox- Introduction iredoxin family, regulates numerous cellular processes through intracellular oxidative signal transduction pathways. Formaldehyde (FA) is an environmental agent commonly Formaldehyde (FA)-induced toxic damage involves reactive found in numerous products, including paint, cloth and oxygen species (ROS) that trigger subsequent toxic effects and exhaust gas, as well as other medicinal and industrial products. inflammatory responses. The present study aimed to inves- FA exposure has raised significant concerns due to mounting tigate the role of Prx2 in the development of bone marrow evidence suggesting its carcinogenic potential and severe toxicity caused by FA and the mechanism underlying FA effects on human health (1). Epidemiological and experi- toxicity. According to the results of the preliminary inves- mental data have demonstrated that FA may cause leukemia, tigations, the mice were divided into four groups (n=6 per particularly myeloid leukemia; however, the mechanism group). One group was exposed to ambient air and the other underlying this effect remains unclear (2-4). In the process three groups were exposed to different concentrations of FA of tumor formation, DNA damage may be the initiating (20, 40, 80 mg/m3) for 15 days in the respective inhalation factor (5), while myeloperoxidase (MPO) activity is associ- chambers, for 2 h a day. -
Peroxiredoxins in Neurodegenerative Diseases
antioxidants Review Peroxiredoxins in Neurodegenerative Diseases Monika Szeliga Mossakowski Medical Research Centre, Department of Neurotoxicology, Polish Academy of Sciences, 5 Pawinskiego Street, 02-106 Warsaw, Poland; [email protected]; Tel.: +48-(22)-6086416 Received: 31 October 2020; Accepted: 27 November 2020; Published: 30 November 2020 Abstract: Substantial evidence indicates that oxidative/nitrosative stress contributes to the neurodegenerative diseases. Peroxiredoxins (PRDXs) are one of the enzymatic antioxidant mechanisms neutralizing reactive oxygen/nitrogen species. Since mammalian PRDXs were identified 30 years ago, their significance was long overshadowed by the other well-studied ROS/RNS defense systems. An increasing number of studies suggests that these enzymes may be involved in the neurodegenerative process. This article reviews the current knowledge on the expression and putative roles of PRDXs in neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and dementia with Lewy bodies, multiple sclerosis, amyotrophic lateral sclerosis and Huntington’s disease. Keywords: peroxiredoxin (PRDX); oxidative stress; nitrosative stress; neurodegenerative disease 1. Introduction Under physiological conditions, reactive oxygen species (ROS, e.g., superoxide anion, O2 -; · hydrogen peroxide, H O ; hydroxyl radical, OH; organic hydroperoxide, ROOH) and reactive nitrogen 2 2 · species (RNS, e.g., nitric oxide, NO ; peroxynitrite, ONOO-) are constantly produced as a result of normal · cellular metabolism and play a crucial role in signal transduction, enzyme activation, gene expression, and regulation of immune response [1]. The cells are endowed with several enzymatic (e.g., glutathione peroxidase (GPx); peroxiredoxin (PRDX); thioredoxin (TRX); catalase (CAT); superoxide dismutase (SOD)), and non-enzymatic (e.g., glutathione (GSH); quinones; flavonoids) antioxidant systems that minimize the levels of ROS and RNS. -
Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4+Cd25high T Cells
biomedicines Article Surface Phenotype Changes and Increased Response to Oxidative Stress in CD4+CD25high T Cells Yoshiki Yamamoto 1,*, Takaharu Negoro 2, Rui Tada 3 , Michiaki Narushima 4, Akane Hoshi 2, Yoichi Negishi 3,* and Yasuko Nakano 2 1 Department of Paediatrics, Tokyo Metropolitan Ebara Hospital, Tokyo 145-0065, Japan 2 Department of Pharmacogenomics, School of Pharmacy, Showa University, Tokyo 142-8555, Japan; [email protected] (T.N.); [email protected] (A.H.); [email protected] (Y.N.) 3 Department of Drug Delivery and Molecular Biopharmaceutics, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan; [email protected] 4 Department of Internal Medicine, Showa University Northern Yokohama Hospital, Kanagawa 224-8503, Japan; [email protected] * Correspondence: [email protected] (Y.Y.); [email protected] (Y.N.); Tel.: +81-3-5734-8000 (Y.Y.); +81-42-676-3182 (Y.N.) + + + + Abstract: Conversion of CD4 CD25 FOXP3 T regulatory cells (Tregs) from the immature (CD45RA ) to mature (CD45RO+) phenotype has been shown during development and allergic reactions. The relative frequencies of these Treg phenotypes and their responses to oxidative stress during devel- opment and allergic inflammation were analysed in samples from paediatric and adult subjects. The FOXP3lowCD45RA+ population was dominant in early childhood, while the percentage of high + FOXP3 CD45RO cells began increasing in the first year of life. These phenotypic changes were observed in subjects with and without asthma. Further, there was a significant increase in phospho- Citation: Yamamoto, Y.; Negoro, T.; + high rylated ERK1/2 (pERK1/2) protein in hydrogen peroxide (H2O2)-treated CD4 CD25 cells in Tada, R.; Narushima, M.; Hoshi, A.; adults with asthma compared with those without asthma. -
Oxidative Protein Biogenesis and Redox Regulation in the Mitochondrial Intermembrane Space
Cell Tissue Res (2017) 367:43–57 DOI 10.1007/s00441-016-2488-5 REVIEW Oxidative protein biogenesis and redox regulation in the mitochondrial intermembrane space Phanee Manganas1 & Lisa MacPherson1 & Kostas Tokatlidis1 Received: 2 June 2016 /Accepted: 5 August 2016 /Published online: 8 September 2016 # The Author(s) 2016. This article is published with open access at Springerlink.com Abstract Mitochondria are organelles that play a central role membrane (IM). The presence of these two membranes allows in cellular metabolism, as they are responsible for processes the formation of two aqueous subcompartments within the such as iron/sulfur cluster biogenesis, respiration and apopto- mitochondria, which are the intermembrane space (IMS) and sis. Here, we describe briefly the various protein import path- the matrix. Each one of these compartments is characterised ways for sorting of mitochondrial proteins into the different by a specific set of proteins that carry out specialised func- subcompartments, with an emphasis on the targeting to the tions. The majority of these proteins are encoded in the nucle- intermembrane space. The discovery of a dedicated redox- ar genome and synthesised in the cytosol, making it necessary controlled pathway in the intermembrane space that links pro- for the mitochondria to possess mechanisms through which to tein import to oxidative protein folding raises important ques- import all the proteins required for the correct function of the tions on the redox regulation of this process. We discuss the organelle (Neupert 1997). During the import process, the in- salient features of redox regulation in the intermembrane coming proteins are targeted to their correct location within space and how such mechanisms may be linked to the more the organelle by utilising a series of different import pathways. -
PRDX4 (Human) ELISA Kit 1
PRDX4 (Human) ELISA Kit 1. The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma. Guo X, Catalog Number: KA2121 Noguchi H, Ishii N, Homma T, Hamada T, Hiraki T, Zhang J, Matsuo K, Yokoyama S, Ishibashi H, Regulatory Status: For research use only (RUO) Fukushige T, Kanekura T, Fujii J, Uramoto H, Tanimoto A, Yamada S. Antioxid Redox Signal. 2018 Apr 24. Product Description: PRDX4 (Human) ELISA Kit is a [Epub ahead of print] sandwich enzyme immunoassay for the quantitative 2. Galectin-3 downregulates antioxidant peroxiredoxin-4 measurement of human PRDX4. in human cardiac fibroblasts: a new pathway to induce cardiac damage? Ibarrola J, Arrieta V, Sadaba R, Suitable Sample: Buffered solution Martinez-Martinez E, Garcia-Pena A, Alvarez V, Fernandez-Celis A, Gainza A, Santamaria E, Sample Volume: 100 uL Fernandez-Irigoyen J, Cachofeiro V, Zalba G, Fay R, Label: HRP-conjugated Rossignol P, Lopez-Andres N. Clin Sci (Lond). 2018 Apr 19. pii: CS20171389. [Epub ahead of print] Detection Method: Colorimetric 3. Overexpression of Peroxiredoxin 4 Affects Intestinal Function in a Dietary Mouse Model of Nonalcoholic Fatty Calibration Range: 78.13 to 5000 pg/mL Liver Disease. Nawata A, Noguchi H, Mazaki Y, Kurahashi T, Izumi H, Wang KY, Guo X, Uramoto H, Limit of Detection: 6.77 pg/mL Kohno K, Taniguchi H, Tanaka Y, Fujii J, Sasaguri Y, Tanimoto A, Nakayama T, Yamada S. PLoS One. 2016 Reactivity: Human Apr 1;11(4):e0152549. Applications: Quant (See our web site product page for detailed applications information) Protocols: See our web site at http://www.abnova.com/support/protocols.asp or product page for detailed protocols Storage Instruction: Store the kit at 4°C. -
Oxidative Stress Modulates the Expression Pattern of Peroxiredoxin-6 in Peripheral Blood Mononuclear Cells of Asthmatic Patients and Bronchial Epithelial Cells
Allergy Asthma Immunol Res. 2020 May;12(3):523-536 https://doi.org/10.4168/aair.2020.12.3.523 pISSN 2092-7355·eISSN 2092-7363 Original Article Oxidative Stress Modulates the Expression Pattern of Peroxiredoxin-6 in Peripheral Blood Mononuclear Cells of Asthmatic Patients and Bronchial Epithelial Cells Hyun Jae Shim ,1 So-Young Park ,2 Hyouk-Soo Kwon ,1 Woo-Jung Song ,1 Tae-Bum Kim ,1 Keun-Ai Moon ,1 Jun-Pyo Choi ,1 Sin-Jeong Kim ,1 You Sook Cho 1* 1Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 2Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea Received: Jul 8, 2019 ABSTRACT Revised: Nov 29, 2019 Accepted: Dec 23, 2019 Purpose: Reduction-oxidation reaction homeostasis is vital for regulating inflammatory Correspondence to conditions and its dysregulation may affect the pathogenesis of chronic airway inflammatory You Sook Cho, MD, PhD diseases such as asthma. Peroxiredoxin-6, an important intracellular anti-oxidant molecule, Division of Allergy and Clinical Immunology, Department of Internal Medicine, Asan is reported to be highly expressed in the airways and lungs. The aim of this study was to Medical Center, University of Ulsan College of analyze the expression pattern of peroxiredoxin-6 in the peripheral blood mononuclear cells Medicine, 88 Olympic-ro 43-gil, Songpa-gu, (PBMCs) of asthmatic patients and in bronchial epithelial cells (BECs). Seoul 05505, Korea. Methods: The expression levels and modifications of peroxiredoxin-6 were evaluated in Tel: +82-2-3010-3285 PBMCs from 22 asthmatic patients. -
1L1 an Outsider S Take on Autism Spectrum Disorders
Plenary Lecture 特別講演 1L1 An outsider’s take on autism spectrum disorders ○Martin Raff MRC LMCB, University College London Autism spectrum disorders(ASDs)are among the commonest neuropsychiatric disorders. Although, until re- cently, ASDs were one of the least understood of these disorders, they are now one of the best understood. Pro- gress has come largely through recent advances in human genetics that have identified rare large!effect muta- tions that cause or greatly increase the risk of these disorders, together with studies of genetic mouse models based on these mutations. Remarkably, in a number of mouse models caused by single mutations, correction of the problem in the adult brain(with either drugs or genetic manipulations)largely reverses many of the behav- ioral and neurobiological abnormalities, providing hope for the development of therapies for individuals with ASDs. In my talk, I will review the basic features of ASDs, using home videos of the development of my 13!year! old autistic grandson as an example, and I will discuss some of the recent advances in ASD research, consider current puzzles, and speculate on possible ways forward. Plenary Lecture 特別講演 2L1 A role of drebrin A in the activity!dependent trafficking of NMDA receptors to the plasma membrane ○Chiye Aoki1,Sho Fujisawa1,Kei Tateyama1,Yi!Wen Chen1,Tomoaki Shirao2 1Center for Neural Science, New York University 2Dept of Neurobiology and Behavior, Gunma Univ Graduate School of Medicine NMDA receptors(NMDARs)are central molecular agents that enable the activity!dependent modification of synaptic strengths at excitatory synapses. However, relatively little is known about the molecular mechanisms regulating NMDAR levels at each synapse. -
Overview on Peroxiredoxin
Mol. Cells 2016; 39(1): 1-5 http://dx.doi.org/10.14348/molcells.2016.2368 Molecules and Cells http://molcells.org Overview Established in 1990 Overview on Peroxiredoxin Sue Goo Rhee* Peroxiredoxins (Prxs) are a very large and highly con- 2-Cys Prxs Tsa1 and Tsa2, two atypical 2-Cys Prxs Ahp1 and served family of peroxidases that reduce peroxides, with a nTpx (where n stands for nucleus), and one 1-Cys mTpx conserved cysteine residue, designated the “peroxidatic” (where m stands for mitochondria) [see the review by by Tole- Cys (CP) serving as the site of oxidation by peroxides (Hall dano and Huang (2016)]. et al., 2011; Rhee et al., 2012). Peroxides oxidize the CP-SH to cysteine sulfenic acid (CP–SOH), which then reacts with CLASSIFICATION another cysteine residue, named the “resolving” Cys (CR) to form a disulfide that is subsequently reduced by an The CP residue is conserved in all Prx enzymes. On the basis appropriate electron donor to complete a catalytic cycle. of the location or absence of the CR, Prxs are classified into 2- This overview summarizes the status of studies on Prxs Cys, atypical 2-Cys, and 1-Cys Prx subfamilies (Chae et al., and relates the following 10 minireviews. 1994b; Rhee et al., 2001; Wood et al., 2003b). 2-Cys Prx en- 1 zymes are homodimeric and contain two conserved (CP and CR) cysteine residues per subunit. The CP–SOH reacts with the NOMENCLATURE CR–SH of the other subunit to form an intersubunit disulfide. In atypical 2-Cys PrxV, the CP–SOH reacts with the CR–SH of the As in all biology, acronyms are overwhelming in Prx literature. -
SUPPLEMENTARY DATA Supplementary Figure 1. The
SUPPLEMENTARY DATA Supplementary Figure 1. The results of Sirt1 activation in primary cultured TG cells using adenoviral system. GFP expression served as the control (n = 4 per group). Supplementary Figure 2. Two different Sirt1 activators, SRT1720 (0.5 µM or 1 µM ) and RSV (1µM or 10µM), induced the upregulation of Sirt1 in the primary cultured TG cells (n = 4 per group). ©2016 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db15-1283/-/DC1 SUPPLEMENTARY DATA Supplementary Table 1. Primers used in qPCR Gene Name Primer Sequences Product Size (bp) Sirt1 F: tgccatcatgaagccagaga 241 (NM_001159589) R: aacatcgcagtctccaagga NOX4 F: tgtgcctttattgtgcggag 172 (NM_001285833.1) R: gctgatacactggggcaatg Supplementary Table 2. Antibodies used in Western blot or Immunofluorescence Antibody Company Cat. No Isotype Dilution Sirt1 Santa Cruz * sc-15404 Rabbit IgG 1/200 NF200 Sigma** N5389 Mouse IgG 1/500 Tubulin R&D# MAB1195 Mouse IgG 1/500 NOX4 Abcam† Ab133303 Rabbit IgG 1/500 NOX2 Abcam Ab129068 Rabbit IgG 1/500 phospho-AKT CST‡ #4060 Rabbit IgG 1/500 EGFR CST #4267 Rabbit IgG 1/500 Ki67 Santa Cruz sc-7846 Goat IgG 1/500 * Santa Cruz Biotechnology, Santa Cruz, CA, USA ** Sigma aldrich, Shanghai, China # R&D Systems Inc, Minneapolis, MN, USA † Abcam, Inc., Cambridge, MA, USA ‡ Cell Signaling Technology, Inc., Danvers, MA, USA ©2016 American Diabetes Association. Published online at http://diabetes.diabetesjournals.org/lookup/suppl/doi:10.2337/db15-1283/-/DC1 SUPPLEMENTARY DATA Supplementary -
The Prognostic Values of the Peroxiredoxins Family in Ovarian Cancer
Bioscience Reports (2018) 38 BSR20180667 https://doi.org/10.1042/BSR20180667 Research Article The prognostic values of the peroxiredoxins family in ovarian cancer Saisai Li, Xiaoli Hu, Miaomiao Ye and Xueqiong Zhu Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou 325027, Zhejiang, China Correspondence: Xueqiong Zhu ([email protected]) Purpose: Peroxiredoxins (PRDXs) are a family of antioxidant enzymes with six identified mammalian isoforms (PRDX1–6). PRDX expression is up-regulated in various types of solid tumors; however, individual PRDX expression, and its impact on prognostic value in ovarian cancer patients, remains unclear. Methods: PRDXs family protein expression profiles in normal ovarian tissues and ovarian cancer tissues were examined using the Human Protein Atlas database. Then, the prog- nostic roles of PRDX family members in several sets of clinical data (histology, pathological grades, clinical stages, and applied chemotherapy) in ovarian cancer patients were investi- gated using the Kaplan–Meier plotter. Results: PRDXs family protein expression in ovarian cancer tissues was elevated com- pared with normal ovarian tissues. Meanwhile, elevated expression of PRDX3, PRDX5, and PRDX6 mRNAs showed poorer overall survival (OS); PRDX5 and PRDX6 also predicted poor progression-free survival (PFS) for ovarian cancer patients. Furthermore, PRDX3 played sig- nificant prognostic roles, particularly in poor differentiation and late-stage serous ovarian cancer patients. Additionally, PRDX5 predicted a lower PFS in all ovarian cancer patients treated with Platin, Taxol, and Taxol+Platin chemotherapy. PRDX3 and PRDX6 also showed poor PFS in patients treated with Platin chemotherapy. Furthermore, PRDX3 and PRDX5 indicated lower OS in patients treated with these three chemotherapeutic agents. -
Role of Peroxiredoxin 6 in Human Melanoma
Role of Peroxiredoxin 6 in human melanoma Dissertation zur Erlangung des naturwissenschaftlichen Doktorgrades der Bayerischen Julius-Maximilians-Universität Würzburg vorgelegt von Alexandra Schmitt aus Würzburg Würzburg 2015 Eingereicht am:__________________________ Mitglieder der Promotionskommission: Vorsitzender:____________________________ Gutachter:______________________________ Gutachter:______________________________ Tag des Promotionskolloquiums:___________________ Doktorurkunde ausgehändigt am:___________________ Eidesstattliche Erklärung Gemäß §4, Abs. 3, Ziff. 3, 5 und 8 der Promotionsordnung der Fakultät für Biologie der Bayerischen Julius-Maximilians-Universität Würzburg Hiermit erkläre ich ehrenwörtlich, dass ich die vorliegende Dissertation selbständig angefertigt und keine anderen als die angegebenen Quellen und Hilfsmittel verwendet habe. Ich erkläre weiterhin, dass die vorliegende Dissertation weder in gleicher, noch in ähnlicher Form bereits in einem anderen Prüfungsverfahren vorgelegen hat. Weiterhin erkläre ich, dass ich außer den mit dem Zulassungsantrag urkundlich vorgelegten Graden keine weiteren akademischen Grade erworben oder zu erwerben versucht habe. Würzburg, Januar 2015 ______________________________________ Alexandra Schmitt Table of contents 1. Abstract ................................................................................................................. 1 2. Zusammenfassung ............................................................................................... 3 3. Introduction .......................................................................................................... -
Kinetic Approaches to Measuring Peroxiredoxin Reactivity
Mol. Cells 2016; 39(1): 26-30 http://dx.doi.org/10.14348/molcells.2016.2325 Molecules and Cells http://molcells.org Established in 1990 Kinetic Approaches to Measuring Peroxiredoxin Reactivity Christine C. Winterbourn*, and Alexander V. Peskin Peroxiredoxins are ubiquitous thiol proteins that catalyse demonstrated surprisingly low reactivity with thiol reagents such the breakdown of peroxides and regulate redox activity in as iodoacetamide and other oxidants such as chloramines the cell. Kinetic analysis of their reactions is required in (Peskin et al., 2007) and it is clear that the low pKa of the active order to identify substrate preferences, to understand how site thiol is insufficient to confer the high peroxide reactivity. In molecular structure affects activity and to establish their fact, typical low molecular weight and protein thiolates react -1 -1 physiological functions. Various approaches can be taken, with H2O2 with a rate constant of 20 M s whereas values of including the measurement of rates of individual steps in Prxs are 105-106 fold higher (Winterbourn and Hampton, 2008). the reaction pathway by stopped flow or competitive kinet- An elegant series of structural and mutational studies (Hall et al., ics, classical enzymatic analysis and measurement of pe- 2010; Nakamura et al., 2010; Nagy et al., 2011) have shown roxidase activity. Each methodology has its strengths and that to get sufficient rate enhancement, it is necessary to acti- they can often give complementary information. However, vate the peroxide. As discussed in detail elsewhere (Hall et al., it is important to understand the experimental conditions 2010; 2011), this involves formation of a transition state in of the assay so as to interpret correctly what parameter is which hydrogen bonding of the peroxide to conserved Arg and being measured.